Research Solutions, Inc. (FRA:61I)
Germany · Delayed Price · Currency is EUR | Market Cap | 57.12M -34.0% |
| Revenue (ttm) | 42.28M -1.5% |
| Net Income | 2.47M +123.0% |
| EPS | 0.08 +121.9% |
| Shares Out | n/a |
| PE Ratio | 21.71 |
| Forward PE | 13.23 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Open | 1.720 |
| Previous Close | 1.690 |
| Day's Range | 1.720 - 1.720 |
| 52-Week Range | 1.630 - 2.820 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |
About Research Solutions
Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.ai and Scite.ai products, a tools that allows for searching and identify... [Read more]
Financial Performance
In fiscal year 2026, Research Solutions's revenue was $48.31 million, a decrease of -1.53% compared to the previous year's $49.06 million. Earnings were $2.82 million, an increase of 122.99%.
Financial numbers in USD Financial StatementsNews
Research Solutions' Scite & MDPI Collaborate to Make Open Access Research Discoverable, Attributed, & Measurable Inside AI Tools
MDPI Journals Are Now Indexed in Scite & Discoverable Through the Scite MCP, Giving Researchers Cited Access to MDPI Content in Claude, ChatGPT, & Other AI Environments BASEL, Switzerland and HENDERSO...
Research Solutions Proxy statement: Proxy filing
Research Solutions filed a proxy statement on October 1, 2026, providing details for shareholder voting and corporate governance matters.
Research Solutions Proxy statement: Proxy filing
Research Solutions filed a proxy statement on October 1, 2026, providing details for shareholder voting and corporate governance matters.
Research Solutions announces availability of Article Galaxy as a ChatGPT plugin
Research Solutions (RSSS) announces the availability of Article Galaxy as a ChatGPT plugin. The release brings the company’s scientific article access and document delivery capabilities directly into ...
Research Solutions Launches Article Galaxy Plugin In The ChatGPT Plugin Directory, Bringing Rights-Cleared Article Access To AI Research Workflows
Researchers Can Now Check Article Availability, Confirm Access & Reuse Rights, & Order Scientific Literature Through Their Article Galaxy Account Within The ChatGPT Conversation HENDERSON, Nev., Sept....
Research Solutions Earnings Call Transcript: Q4 2026
B2B ARR grew 14% and platform revenue rose to 43% of total, while AI products drove $800K in Q4 bookings and a strong FY 2027 pipeline. Gross margin hit a record 53% in Q4, and net income for FY 2026 more than doubled YoY. Cash position remains strong with no debt.
Research Solutions Earnings release: Q4 2026
Research Solutions released its Q4 2026 earnings on September 9, 2026, summarizing the period's financial results.
Research Solutions Annual report: Q4 2026
Research Solutions has published its Q4 2026 annual report on September 9, 2026.
Research Solutions reports Q4 EPS 2c, consensus 4c
Reports Q4 revenue $12.1M, consensus $11.95M. “We launched multiple products in fiscal 2026, including new AI based products. Two of the AI products, Scite MCP and Article Galaxy MCP, allow…
Research Solutions Reports Fourth Quarter and Fiscal Year 2026 Results
Reports Record Fiscal Year Net Income of $2.8 Million, 14% YoY B2B ARR Increase and ARR of $22.5 Million HENDERSON, Nev., Sept. 9, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the le...
Research Solutions to Announce Fourth Quarter and Fiscal Year 2026 Results on Wednesday, September 9, 2026
HENDERSON, Nev., Sept. 1, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: RSSS), the leading AI-powered research workflow platform, will hold a conference call to discuss its financial results...
Research Solutions Transcript: 17th Annual Midwest IDEAS Conference
The company has successfully shifted to a SaaS model, boosting margins and revenue stability, while integrating AI connectors to maintain a competitive edge in research workflow solutions. Strong financials, deep industry relationships, and unique content rights underpin its growth strategy.
Research Solutions to Participate at Upcoming Investor Conferences
HENDERSON, Nev., Aug. 18, 2026 /PRNewswire/ -- Research Solutions (RSSS) today announced management will participate at the following investor conferences: Midwest IDEAS Conference August 27Location: ...
Research Solutions Slides: Investor presentation
Research Solutions has posted slides in relation to its latest quarterly earnings report, which was published on August 3, 2026.
Research Solutions Transcript: 16th Annual East Coast IDEAS Conference
The company leverages proprietary agreements with major publishers to deliver research access and analytics through AI-integrated tools, serving a broad customer base. Its scalable platform business drives high margins and growth, while evolving publisher partnerships open new revenue streams.
Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc. today announced an upsized Series E round of financing, including $175 million from longstanding investor Samsung Electronics, and an undisclosed ...
Research Solutions to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY
HENDERSON, Nev., June 4, 2026 /PRNewswire/ -- Research Solutions (RSSS), today announced management will present at the East Coast IDEAS Investor Conference on Wednesday June 10 , 2026 at The Westin T...
Research Solutions price target lowered to $4 from $5 at Lake Street
Lake Street analyst Jacob Stephan lowered the firm’s price target on Research Solutions (RSSS) to $4 from $5 and keeps a Buy rating on the shares. Q3 results were “mixed,”…
Research Solutions price target lowered to $3.50 from $5 at Roth Capital
Roth Capital analyst Richard Baldry lowered the firm’s price target on Research Solutions (RSSS) to $3.50 from $5 and keeps a Buy rating on the shares. Q3 revenues were below…
Research Solutions price target lowered to $4 from $5 at Maxim
Maxim analyst Allen Klee lowered the firm’s price target on Research Solutions (RSSS) to $4 from $5 and keeps a Buy rating on the shares after its Q1 revenue fell…
Research Solutions reports Q3 EPS 3c, consensus 4c
Reports Q3 revenue $12.1M, consensus $12.37M. “We introduced a pair of new AI-based products in recent months, giving Article Galaxy and Scite users the ability to search, review and acquire…
Research Solutions Earnings Call Transcript: Q3 2026
Q3 FY26 saw improved EBITDA and net income, but revenue declined year-over-year due to B2B churn, despite strong new bookings and AI-driven product launches. Gross margin improved, and management expects continued EBITDA growth and stronger cash generation into Q4.
Research Solutions Earnings release: Q3 2026
Research Solutions released its Q3 2026 earnings on May 14, 2026, summarizing the period's financial results.
Research Solutions Quarterly report: Q3 2026
Research Solutions has published its Q3 2026 quarterly earnings report on May 14, 2026.
Research Solutions Reports Third Quarter Fiscal Year 2026 Results
Reports 8.5% Increase in ARR to $22.1 Million, Net Income of $860,000 and 14% Year-over-Year Growth in Adjusted EBITDA HENDERSON, Nev., May 14, 2026 /PRNewswire/ -- Research Solutions, Inc. (NASDAQ: ...